logo
Select company
Select metric
0.68Cash Ratio
VS
Market
58
Sector
32
Industry
18
History
18
$ 11.73Close
$ 5.31 - $ 12.34 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 81.59M0.68$ 119.54M
3/31/2025$ 132.13M1.24$ 106.73M
12/31/2024$ 59.56M0.58$ 103.19M
9/30/2024$ 58.65M0.57$ 102.72M
6/30/2024$ 59.8M0.61$ 98.27M
3/31/2024$ 115M1.04$ 110.18M
12/31/2023$ 36.55M0.28$ 130.27M
9/30/2023$ 55.3M0.43$ 127.35M
6/30/2023$ 70.86M0.6$ 117.89M
3/31/2023$ 72.12M0.64$ 112.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) Cash Ratio stands at 1.49.
  • Over the past 5 years, REGENXBIO INC's average Cash Ratio has been 1.39.
  • The median Cash Ratio for REGENXBIO INC during this period was 1.01
  • REGENXBIO INC reached its highest Cash Ratio over the past 5 years at 4.17.
  • The lowest Cash Ratio recorded by REGENXBIO INC in the same timeframe 0.28

REGENXBIO INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
CTMX : CYTOMX THERAPEUTICS INC 1.28XNCR : XENCOR INC 0.47ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 5.41YMAB : Y-MABS THERAPEUTICS INC 2.71GLUE : MONTE ROSA THERAPEUTICS INC 1.78HRTX : HERON THERAPEUTICS INC 0.06NKTR : NEKTAR THERAPEUTICS 0.6PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC 0.92LXRX : LEXICON PHARMACEUTICALS INC 1.45VNDA : VANDA PHARMACEUTICALS INC 0.67

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for REGENXBIO INC is calculated as follows: CashnEq [ $ 94.55M ] / LiabilitesC [ $ 63.61M ]
(=) Cash Ratio [ 1.49 ]

RGNX - Cash Ratio, Last 5 years

0.28

Minimum

Dec 31, 2023

4.17

Maximum

Dec 31, 2020

1.39

Average

1.01

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63